Log in to save to my catalogue

Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308...

Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b6973abf44e3426bbf320a8690374486

Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank

About this item

Full title

Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank

Publisher

London: Nature Publishing Group UK

Journal title

Translational psychiatry, 2021-04, Vol.11 (1), p.211-211, Article 211

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Cannabis is known to produce acute, transient psychotic-like experiences. However, it is unclear whether cannabis disproportionately increases the risk of specific types of psychotic experiences and whether genetic predisposition influences the relationship between cannabis use and psychotic experiences. In this cross-sectional study of 109,308 UK...

Alternative Titles

Full title

Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b6973abf44e3426bbf320a8690374486

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b6973abf44e3426bbf320a8690374486

Other Identifiers

ISSN

2158-3188

E-ISSN

2158-3188

DOI

10.1038/s41398-021-01330-w

How to access this item